Clinical Practice Guidelines for the Management of Schizophrenia in Children and Adolescents

Overview

Journal Indian J Psychiatry

Specialty Psychiatry

Date 2019 Feb 13

PMID 30745703

Citations 10

Authors

Sandeep Grover

Ajit Avasthi

Affiliations

Soon will be listed here.

Citing Articles

Clinical practice guidelines for assessment and management of cognitive impairment in schizophrenia.

Grover S, Mohapatra D, Vaitheswaran S, Mehta U, Venkatasubramanian G, Thirthalli J Indian J Psychiatry. 2025; 67(1):65-83.

PMID: 40046487 PMC: 11878460. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_690_24.

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study.

Bogowicz P, Mehta A, Choudhary S, Brhlikova P, Roderick P, McGettigan P J Pharm Policy Pract. 2024; 17(1):2372089.

PMID: 39558965 PMC: 11573336. DOI: 10.1080/20523211.2024.2372089.

Critical appraisal and comparison of recommendations of clinical practice guidelines for the treatment of schizophrenia in children and adolescents: a methodological survey.

Alves M, Bergamaschi C, Barberato-Filho S, Oliveira de Melo D, Mayer R, de Oliveira J BMJ Open. 2023; 13(2):e070332.

PMID: 36746538 PMC: 9906266. DOI: 10.1136/bmjopen-2022-070332.

What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review.

Baeza I, Fortea A, Ilzarbe D, Sugranyes G Paediatr Drugs. 2023; 25(2):135-149.

PMID: 36662369 PMC: 9931829. DOI: 10.1007/s40272-023-00558-x.

Recommendations on Off-Label Drug Use in Pediatric Guidelines.

Meng M, Zhou Q, Lei W, Tian M, Wang P, Liu Y Front Pharmacol. 2022; 13:892574.

PMID: 35754484 PMC: 9218488. DOI: 10.3389/fphar.2022.892574.

References

Sikich L, Frazier J, McClellan J, Findling R, Vitiello B, Ritz L . Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry. 2008; 165(11):1420-31. DOI: 10.1176/appi.ajp.2008.08050756. View

Kumar A, Datta S, Wright S, Furtado V, Russell P . Atypical antipsychotics for psychosis in adolescents. Cochrane Database Syst Rev. 2013; (10):CD009582. PMC: 11339588. DOI: 10.1002/14651858.CD009582.pub2. View

Kasoff L, Ahn K, Gochman P, Broadnax D, Rapoport J . Strong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia. J Child Adolesc Psychopharmacol. 2016; 26(5):428-35. PMC: 4931305. DOI: 10.1089/cap.2015.0103. View

Sarkar S, Grover S . Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis. Indian J Pharmacol. 2013; 45(5):439-46. PMC: 3793512. DOI: 10.4103/0253-7613.117720. View

Schmidt S, Schultze-Lutter F, Schimmelmann B, Maric N, Salokangas R, Riecher-Rossler A . EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry. 2015; 30(3):388-404. DOI: 10.1016/j.eurpsy.2015.01.013. View

Schultze-Lutter F, Michel C, Schmidt S, Schimmelmann B, Maric N, Salokangas R . EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 2015; 30(3):405-16. DOI: 10.1016/j.eurpsy.2015.01.010. View

Fleischhacker W, Simma A . Managing the prodrome of schizophrenia. Handb Exp Pharmacol. 2012; (212):125-34. DOI: 10.1007/978-3-642-25761-2_5. View

Ardizzone I, Nardecchia F, Marconi A, Carratelli T, Ferrara M . Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials. Psychopharmacol Bull. 2010; 43(2):45-66. View

Pagsberg A, Tarp S, Glintborg D, Stenstrom A, Fink-Jensen A, Correll C . Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017; 56(3):191-202. DOI: 10.1016/j.jaac.2016.12.013. View

10.

. International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl. 2005; 48:s120-4. DOI: 10.1192/bjp.187.48.s120. View

11.

Castro-Fornieles J, Parellada M, Soutullo C, Baeza I, Gonzalez-Pinto A, Graell M . Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. J Child Adolesc Psychopharmacol. 2008; 18(4):327-36. DOI: 10.1089/cap.2007.0138. View

12.

Findling R, Johnson J, McClellan J, Frazier J, Vitiello B, Hamer R . Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. J Am Acad Child Adolesc Psychiatry. 2010; 49(6):583-94. PMC: 2882800. DOI: 10.1016/j.jaac.2010.03.013. View

13.

Schimmelmann B, Schmidt S, Carbon M, Correll C . Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach. Curr Opin Psychiatry. 2013; 26(2):219-30. DOI: 10.1097/YCO.0b013e32835dcc2a. View

14.

Kumra S, Oberstar J, Sikich L, Findling R, McClellan J, Vinogradov S . Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull. 2007; 34(1):60-71. PMC: 2632383. DOI: 10.1093/schbul/sbm109. View

15.

Fraguas D, Correll C, Merchan-Naranjo J, Rapado-Castro M, Parellada M, Moreno C . Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol. 2010; 21(8):621-45. DOI: 10.1016/j.euroneuro.2010.07.002. View

16.

Olfson M, Gerhard T, Huang C, Lieberman J, Bobo W, Crystal S . Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia. Schizophr Bull. 2011; 38(4):845-53. PMC: 3406514. DOI: 10.1093/schbul/sbq172. View

17.

Grover S, Malhotra S, Varma S, Chakrabarti S, Avasthi A, Mattoo S . Electroconvulsive therapy in adolescents: a retrospective study from north India. J ECT. 2013; 29(2):122-6. DOI: 10.1097/YCT.0b013e31827e0d22. View

18.

Harvey R, James A, Shields G . A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia. CNS Drugs. 2016; 30(1):27-39. DOI: 10.1007/s40263-015-0308-1. View

19.

Datta S, Kumar A, Wright S, Furtado V, Russell P . Evidence base for using atypical antipsychotics for psychosis in adolescents. Schizophr Bull. 2013; 40(2):252-4. PMC: 3932092. DOI: 10.1093/schbul/sbt196. View

20.

Jacob P, Gogi P, Srinath S, Thirthalli J, Girimaji S, Seshadri S . Review of electroconvulsive therapy practice from a tertiary Child and Adolescent Psychiatry Centre. Asian J Psychiatr. 2014; 12:95-9. DOI: 10.1016/j.ajp.2014.06.023. View